A Self-Fulfilling Prophecy: Comparing Lu-177-PSMA Radioligand Therapy in Taxane-Naive Versus Posttaxane Metastasized Prostate Cancer Patients?
Kambiz Rahbar, Michael S Hofman, Andres J Schrader, Martin Boegemann
Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2019
The University of Munster received consulting fees from ABX GmbH, Radeberg, Germany, for Kambiz Rahbar and Martin Bogemann. Additionally, Kambiz Rahbar is scientific advisor of ABX GmbH. Peter MacCallum Cancer Centre has received research funds from Endocyte; Michael S. Hofman is chair of the TheraP study, which is supported by Endocyte. No other potential conflict of interest relevant to this article was reported.